| PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis T Wartewig, Z Kurgyis, S Keppler, K Pechloff, E Hameister, R Öllinger, ... Nature 552 (7683), 121-125, 2017 | 246 | 2017 |
| Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity J Park, J Daniels, T Wartewig, KG Ringbloom, ME Martinez-Escala, ... Blood, The Journal of the American Society of Hematology 138 (14), 1225-1236, 2021 | 61 | 2021 |
| The uric acid crystal receptor Clec12A potentiates type I interferon responses K Li, K Neumann, V Duhan, S Namineni, AL Hansen, T Wartewig, ... Proceedings of the National Academy of Sciences 116 (37), 18544-18549, 2019 | 39 | 2019 |
| Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells T Patzelt, SJ Keppler, O Gorka, S Thoene, T Wartewig, M Reth, I Förster, ... Proceedings of the National Academy of Sciences 115 (12), 3120-3125, 2018 | 38 | 2018 |
| PD-1 tumor suppressor signaling in T cell lymphomas T Wartewig, J Ruland Trends in immunology 40 (5), 403-414, 2019 | 32 | 2019 |
| Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state F Ghazavi, J Huysentruyt, J De Coninck, S Kourula, S Martens, ... Proceedings of the National Academy of Sciences 119 (6), e2024508119, 2022 | 9 | 2022 |
| Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation Z Kurgyis, L Vornholz, K Pechloff, LV Kemény, T Wartewig, ... Science Immunology 6 (65), eabi4425, 2021 | 8 | 2021 |
| Erratum: PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis T Wartewig, Z Kurgyis, S Keppler, K Pechloff, E Hameister, R Öllinger, ... Nature 553 (7687), 238-238, 2018 | 7 | 2018 |
| PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma T Wartewig, J Daniels, M Schulz, E Hameister, A Joshi, J Park, E Morrish, ... Nature Cancer 4 (10), 1508-1525, 2023 | 5 | 2023 |
| Fast 3D hyperpolarized 13 C metabolic MRI at 7T using spectrally selective bSSFP JG Skinner, G Topping, I Heid, M Aigner, M Grashei, C Hundshammer, ... Digital Poster at ISMRM2020 International Conference, 2020 | 2 | 2020 |
| Das Spektrum des Frobenius-Perron-Operators im Fall schwach-gekoppelter Abbildungen T Wartewig, O Junge Bachelor’s Thesis, Technische Universität München, 2010 | 1 | 2010 |
| Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity F Baumgartner, SA Bamopoulos, L Faletti, HJ Hsiao, M Holz, ... Science Signaling 17 (824), eadc9662, 2024 | | 2024 |
| The fusion oncogene VAV1‐MYO1F triggers aberrant T‐cell receptor signaling in vivo and drives peripheral T‐cell lymphoma in mice E Morrish, T Wartewig, A Kratzert, M Rosenbaum, K Steiger, J Ruland European Journal of Immunology 53 (3), 2250147, 2023 | | 2023 |
| IFITM3 Acts As a PIP3 Scaffold in TCR-PI3K Signaling A Takeda, J Lee, T Wartewig, A Bigogno, D Fonseca Arce, M Müschen Blood 140 (Supplement 1), 3030-3031, 2022 | | 2022 |
| CD25 As Feedback Regulator of Oncogenic TCR Signaling in T-Cell Lymphoma R Sun, J Lee, T Wartewig, ME Robinson, A Bigogno, D Fonseca Arce, ... Blood 140 (Supplement 1), 5975-5976, 2022 | | 2022 |
| PD1 regulates T cell exhaustion phenotypes and disease aggressiveness in CTCL J Daniels, J Park, T Wartewig, ME Martinez-Escala, B Pro, J Sosman, ... European Journal of Cancer 156, S2-S3, 2021 | | 2021 |
| Analysis of tumor evolution in a model of T-NHL T Wartewig Technische Universität München, 2020 | | 2020 |
| PD-1 als Tumorsuppressor in T-Zellen entdeckt T Wartewig TumorDiagn u Ther, 39, 2018 | | 2018 |
| Characterization of glycolytic phenotypes using hyperpolarized 13 C-MR and [18 F] FDG PET in endogenous T-cell lymphomas in mice FHA van Heijster, JG Skinner, T Wartewig, C Hundshammer, M Grashei, ... | | |
